Orion Corporation’s financial reporting and Annual General Meeting in 2026

Financial Reporting Schedule - Orion Corporation will publish its Financial Statement Release for 2025 on Thursday, 12 February 2026 [1] - The Interim Reports and Half-Year Financial Report for 2026 will be published on the following dates: - Interim Report for January-March 2026: Thursday, 23 April 2026 - Half-Year Financial Report for January-June 2026: Friday, 17 July 2026 - Interim Report for January-September 2026: Wednesday, 28 October 2026 [1] Annual General Meeting - The Annual General Meeting is scheduled for Tuesday, 24 March 2026 [2] Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing human and veterinary pharmaceuticals and active pharmaceutical ingredients [2] - The company has a diverse portfolio that includes proprietary and generic medicines as well as consumer health products, with core therapy areas in oncology and pain [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] - Orion's A and B shares are listed on Nasdaq Helsinki [2]